FDA recall, , Moderate risk
Dechra Ophthavet Ophthalmic Solution for Dogs and Cats
Ophthavet Ophthalmic Solution has a potential quality concern at the manufacturing site.
Summary by Recall Canary from the FDA notice
What happened
Dechra Veterinary Products Inc. recalled Ophthavet Ophthalmic Solution, 0.18% Viscoadaptive Sodium Hyaluronate, 10 mL (0.33 fl oz), manufactured for Dechra Veterinary Products, 7015 College Boulevard, Suite 525, Overland Park, KS 66211 USA, for use in dogs and cats. The recall was initiated on April 30, 2026, due to a potential quality concern at the manufacturing site, specifically a lack of sterility assurance. The product was distributed nationwide in the US.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for recalled products:
- Check the brand, package size and codes such as expiration dates against the notice.
- Return it to the store where you bought it, or dispose of it properly.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Ophthavet Ophthalmic Solution, 0.18% Viscoadaptive Sodium Hyaluronate
- NDC
- 17033-045-10
- Lot code
- 9T84
Recall details
- Company began the recall
- Sold in
US Nationwide.
- Company
- Dechra Veterinary Products Inc
- Hazard
- Sterility problem
- Risk
Moderate risk
It may cause short-term health problems in animals it is used on, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98896
- Recall number
- V-0129-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Listed on Recall Canary
In FDA's weekly enforcement report
Classified by FDA
Summary updated
